comparemela.com

Page 3 - I Peace Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I Peace accelerates allogeneic iPSC-derived cell therapies with g high throughput method to identify a large number of donors with specific HLA haplotypes

/PRNewswire/ I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up in the field of GMP cell manufacturing CDMO, announced that the company,.

iPSCs Manufacturing Services Market worth $2 61 Billion by 2030 - Exclusive Report by InsightAce Analytic

I Peace triples GMP cell manufacturing by expanding CDMO facility

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.